Search

shutterstock_2261453831(1) (1)

Announcements

Announcements

HOMEWhat’s NewAnnouncements

2023.Feb.02

OBI filed application for Phase II human clinical trial of first-in-class novel prodrug, OBI-3424, to TFDA

2023.Jan.14

Announcement on behalf of AP Biosciences that application for Phase I human clinical trial of Bispecific Antibody, AP505, has been granted by US FDA

2022.Dec.30

Announcement of BOD’s resolution to lift the non-competition restrictions for new CEO

2022.Dec.30

Announcement of change of CEO

2022.Dec.30

Announcement of change of the spokesperson

2022.Dec.30

Announcement of change of Chairman of the Board

2022.Dec.29

Announcement of death of Chairman of the Board (Supplementary Statement on the circumstances of his deputy)

2022.Dec.29

Announcement of change of director

2022.Dec.29

Announcement of death of Chairman of the Board

2022.Dec.23

OBI-866 ”Immunogenic/Therapeutic Glycan Compositions And Uses Thereof“ Was Granted By USPTO

News

Latest News

Events

Latest events